Standout Papers

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant ... 2016 2026 2019 2022 385
  1. Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia (2017)
    Ryan K. Shields, M. Hong Nguyen et al. Antimicrobial Agents and Chemotherapy
  2. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections (2016)
    Ryan K. Shields, Liang Chen et al. Antimicrobial Agents and Chemotherapy

Immediate Impact

4 from Science/Nature 97 standout
Sub-graph 1 of 17

Citing Papers

Cefepime–Taniborbactam in Complicated Urinary Tract Infection
2024 Standout
Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability
2024 Standout
2 intermediate papers

Works of Ellen G. Press being referenced

Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature
2017
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.
2016
and 3 more

Author Peers

Author Last Decade Papers Cites
Ellen G. Press 2139 1578 811 1284 28 3.0k
Brian A. Potoski 2334 1496 1032 1297 55 3.6k
Sheryl Zelenitsky 1948 2068 990 1293 79 4.2k
Alfred S. Gin 1706 1551 824 1044 37 3.3k
Samuel L Aitken 1769 1159 861 1302 106 3.3k
Maria Souli 2405 1159 502 883 68 3.2k
M. Warner 1749 817 570 640 38 2.4k
Gregory G. Stone 2213 1572 736 958 111 3.6k
Samuel K. Bouchillon 1883 1035 399 659 50 2.5k
Andrea Lay‐Hoon Kwa 1613 1111 526 1253 122 3.2k
Marina Warner 1913 1045 397 550 44 2.4k

All Works

Loading papers...

Rankless by CCL
2026